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and history of impaired medication management were significant in univariate 
analysis (p<0.2) and entered into a multivariate linear regression model for the 
primary outcome. The overall regression model was significant (p=0.009, R-
squared=0.029), and the number of Beers medications was found to be an 
independent predictor of number of DTPs (p=0.008). Univariate variables 
significantly associated with indication-related problems included race, vision 
impairment, and living alone, but only race remained significant (p=0.013) in a 
regression model (p=0.007, R-squared=0.055). For adherence-related problems, 
race, Beers medications, and ethnicity were significant by univariate analysis, 
but only race (p=0.002) and Beers medications (p=0.048) remained significant in 
the regression model (p=0.002, R-squared=0.074). CONCLUSIONS: Through 
identification of predictors of DTPs, these results may inform allocation of MTM 
resources among this population.  
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OBJECTIVES: Polypharmacy (≥5medications) is common among older patients 
(>65 old) and is linked to increased risk of adverse health outcomes resulting in 
hospitalizations and sometimes death. This study aims to explore the 
association of polypharmacy and self-perceived health status (SPHS) among 
geriatric patients. METHODS: This longitudinal observational research used 
Medical Expenditure Panel Survey household component (MEPS-HC), a national 
survey data from 2005-2008. National estimates on individuals were estimated 
using longitudinal weights provided by MEPS. Overall SPHS was assessed using 
the MEPS health and well-being variable. Multivariate logistic regressions 
examined likelihood of having a “Good” or “Poor” SPHS and polypharmacy 
(≥5medications). RESULTS: Study included a total of 102,309,656 weighted 
individuals reported from survey of 4775 actual individuals from 2005-2008. 
Patient’s mean age was 74.7 years (SE±0.138) 58.1% women, 87.3% Caucasian, 
56.8% married, 37.8% were from the southern region of USA. About 69% of 
patients reported polypharmacy. The most prevalent disease reported was 
hypertension (62.7%). Overall, 78% of seniors reported SPHS as “Good” while 22% 
reported SPHS as “Poor”. Among polypharmacy users, 72.52% reported “Good” 
SPHS; 27.48% for “Poor” compared to non-polypharmacy seniors who reported 
90.8% “Good” and 9.02% for “Poor”. Logistic regression adjusted for covariates 
showed that non-polypharmacy users are about three times more likely to report 
SPHS as “Good” (OR=2.73;95%CI:2.11–3.54;P=0.000001). CONCLUSIONS: We 
observed significant differences in baseline characteristics and SPHS between 
polypharmacy and non-polypharmacy users. Non-polypharmacy users perceived 
their health status to be better than polypharmacy users. Mediation 
reconciliation among older patients may prevent polypharmacy and improve 
health status.  
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OBJECTIVES: Therapeutic duplicate (TD) is one of the most frequently reported 
inappropriate drug use. This study was conducted to estimate the prevalence of 
therapeutic duplications in ambulatory setting in Korea and to determine the 
patient, physician and visits characteristics associated with TD of NSAIDs. 
METHODS: The prevalence of TD of NSIADs was examined by analyzing Korea’s 
National Health Insurance claims database from January to March 2011. KFDA 
TD classification was used as the TD criteria which includes 64 ingredients. 
Multivariate logistic regression was used to determine predictors of the 
prescribing of TD at ambulatory care visits. Independent variables in the 
regression model included patient characteristics (gender, age, insurance type, 
comorbidity), physician characteristics (type of medical institution, specialty), 
and visit characteristics (the number of drugs). RESULTS: Overall 59,636,222 
ambulatory care visits of 21 million patients were identified in the 1st quarter of 
2011. And of these visits, 13.3% were involved in TD. The most frequent 
duplication were occurred between diclofenac and aceclofenac (12.4% of TD), 
diclofenac and talniflumate (11.2%), and diclofenac and loxoprofen sodium 
(10.7%). The patient characteristics associated with an increased likelihood of TD 
were male (OR=1.070 (95% CI=1.069-1.072), older age (18-39 years OR=1.055, 95% 
CI=1.051-1.059; 40-64 years OR=1.257, 95% CI=1.253-1.262; 65-74 years OR=1.283, 
95% CI=1.278-1.288; 75 years older OR=1.231, 95% CI=1.226-1.236), and charlson 
comorbidity index ≥1 (OR=1.075, 95% CI=1.071-1.078). Physician characteristics 
associated with increased likelihood of TD were orthopedics (OR=2.091, 95% 
CI=2.086 - 2.096) and pediatrics (OR=1.314, 95% CI=1.308-1.320). And the number 
of drugs per prescription was associated with an increased likelihood of TD (4-6 
OR=2.054, 95% CI=2.050-2.058; ≥7 OR=2.695, 95% CI=2.687-2.704). CONCLUSIONS: 
This study is the first study which demonstrated the prevalence of therapeutic 
duplication among NSAIDs and associated factors in Korea. And these results 
could contribute to both preventing therapeutic duplication and improving 
appropriate medication use.  
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OBJECTIVES: The growth in per-member-per-year (PMPY) prescription drug 
utilization among beneficiaries with private or commercial health insurance 
coverage has slowed over the past six years, after nearly a decade of steady 
growth. This is somewhat surprising as the U.S. population ages, the rising 
prevalence of obesity and related conditions, more choices in lower cost generic 
medications, and newer drugs to treat chronic conditions. Particularly for the 
commercially insured population where the beneficiary is responsible only for 
deductibles and co-payments, one might expect the trajectory of prescription 
drug utilization growth to continue uninterrupted. METHODS: Summarized 
annual utilization statistics from a large pharmacy benefit manager and publicly 
available data from 1997-2011 was used. Because growth rates may be auto-
correlated and a general time trend was evident, we used retrospective time 
series analysis methods to adjust for auto-correlation and represented our 
covariates as first differences to make the series stationary. RESULTS: Our final 
model contained two covariates in addition to a regression intercept and an 
auto-regressive parameter: percentage of full-time employees in labor unions 
and number of “baby boom” generation persons (born between 1946 and 1964) 
turning age 50. Parameter estimates were 0.0113 (p=0.0374) and 2.8064 (p=0.0074) 
respectively. CONCLUSIONS: We believe that the labor union parameter is an 
overall reflection of employee cost-share and economic conditions related to the 
economic recession which started in 2007 and slow recovery since the official 
end of the recession in 2009. This was exacerbated by changing demographics as 
baby boomers become eligible for Medicare and are no longer covered by private 
insurance. Decreased birth rates following the baby boomer cohort have for the 
time, reduced the available pool of Americans turning 50 each year when the use 
of chronic medications becomes more common.  
 
PHP44  
ASSESSMENT OF PATIENTS' KNOWLEDGE OF DRUG THERAPY IN A NIGERIAN 
HEALTH CARE FACILITY  
Enato E1, Obi V1, Dayom W2 
1University of Benin, Benin, Nigeria, 2University of Benin, Benin, Nigeria  
OBJECTIVES: Patients’ knowledge of their medications is an important factor in 
ensuring adherence. Medication adherence is essential for rational drug use and 
derivation of optimal therapy. This study was conducted to assess the 
knowledge of outpatients regarding their medications METHODS: A well 
structured questionnaire was administered to 200 patients just after being 
attended to at the general outpatient pharmacy of University of Benin Teaching 
Hospital, Nigeria. 180 filled questionnaires that met the study criteria were 
compiled and analysed. Frequencies were calculated and differences between 
proportions explored using Chi-squared test. RESULTS: Results showed that 
most patients lack knowledge of their medications. Age and level of education 
was found to significantly (p<0.05) influence their knowledge of medications; 
while on the other hand, sex had no influence on patients’ knowledge of 
medication. The study further revealed that lack of knowledge of drug name, 
indication and consequence of dose omission had very significant (p<0.001) 
influence on patients’ adherence. Thirty nine percent of patients reported that 
they sometimes forget to take their drugs, while 19% miss doses of their drugs 
for other reasons, including being busy at work/school, tiredness or when 
fasting. 39% stop taking their drugs when they are feeling better, while 19% 
refuse to continue with their drugs for some other reasons, including side effects 
(76%) and bad taste or odour of the drugs. CONCLUSIONS: We recommend, 
therefore, that elaborate patient counselling, covering every aspect of medication 
therapy should be provided by health care professionals in order to improve 
patient’s medication knowledge and adherence.  
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OBJECTIVES: To determine whether the formation of Drugs and Therapeutics 
Committees (DTC’s) to implement Rational Drug Use Policies has impacted 
positively on prescribing patterns at Ussher Polyclinic. METHODS: The double 
differencing method was employed in this study. Data for the period 1990 – 2009 
were collected from prescription sheet of patients attending to the outpatient 
department of Ussher polyclinic and a private clinic. Data was analyzed using 
Microsoft Office Excel 2007. Fourteen thousand four hundred prescriptions 
sheets were analyzed from both clinics using systematic random sampling. 
Variations of rational prescribing indicators from their optimal values (as 
determined by WHO standards) were determined and the mean values used in 
the determination of the difference- in -difference estimate. Subtracting the 
change in prescribing indicator of the private clinic without a DTC over the two 
time periods( 1990–2000 and 2000–2009) from the change observed at Ussher 
polyclinic with a functioning DTC from the year 2000, over the same time 
periods(1990-2000 and 2000-2009) gives the Difference-in-Difference estimate. 
RESULTS: The Difference-in-Difference (DiD) estimate showed that reduction in 
average number of drugs prescribed was 0.63 units lower at Ussher polyclinic 
compared to the private clinic after the post-intervention period. The use of 
antibiotics was 8.72% lower at Ussher Polyclinic as compared to the private 
hospital. Reduction in injection use was 25.76% lower at Ussher Polyclinic 
compared to the private clinic. Improvement in generic prescribing was 44.62% 
higher at Ussher Polyclinic compared to the private clinic. Increased adherence 
to prescribing according to Essential Drug List was 43.74% higher at Ussher 
Polyclinic compared to the private clinic. CONCLUSIONS: The overall picture 
suggests that implementation of rational drug use policies have impacted 
